N/A
Completed N=106
Evaluating an Analogy-Based Consultation Approach for Insulin-Treated Type 2 Diabetes Patients
Source: ClinicalTrials.gov NCT07265245 ↗Enrolled (actual)
106
Serious AEs
0.0%
Results posted
Jan 2026
Primary outcomePrimary: HbA1c — 10.31 Percentage (%) of HbA1c
Summary
The goal of this retrospective interventional study is to learn whether a new consultation approach called M2-PRIME can help improve blood sugar control in people with type 2 diabetes who use insulin and have high blood sugar levels (HbA1c more than 8.5%).
The main questions are:
1. Does using M2-PRIME during consultations help lower HbA1c (3-month average blood sugar level)?
2. Does using M2-PRIME help lower fasting blood sugar (FBS, morning blood sugar)?
In this study, participants received their regular diabetes care at the Self-Monitoring of Blood Glucose (SMBG) clinic, which runs once a week. Two primary healthcare providers (PHPs) trained in the M2-PRIME framework provided the consultations.
During each visit, PHPs used M2-PRIME to:
1. Build rapport and review the participant's health and lifestyle,
2. Give simple advice about food, activity, and insulin use,
3. Use the "Garbage and Lorry" analogy to explain how the body handles sugar, 4. Educate regarding insulin self-adjustment and monitoring
5. Adjust insulin doses when needed
Each participant had three consultations over six months. Their HbA1c and fasting blood glucose were measured at the start and after six months to see if their blood sugar control improved.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY HbA1c |
10.31 | — |
| SECONDARY Fasting Blood Sugar |
9.22 | — |
Eligibility Criteria
Inclusion Criteria
- Established T2DM patients, already on insulin therapy regardless of the type of insulin or regime or duration of treatment
- HbA1c at referral more than 8.5%
- Already seen by diabetic educator or dietician prior to referral
Exclusion Criteria
- Pregnant or found to be pregnant during follow-up
Data sourced from ClinicalTrials.gov (NCT07265245). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.